Literature DB >> 18030415

Paternal transmission and slow elimination of mutant alleles associated with late-onset ornithine transcarbamylase deficiency in male patients.

Sanae Numata1, Eimei Harada1, Yasuki Maeno1, Isao Ueki1, Yoriko Watanabe1, Chieko Fujii1, Takashi Yanagawa2, Satoshi Takenaka3, Toshiro Inoue3, Shinkai Inoue4, Terufumi Goushi4, Tsutomu Yasutake5, Toshihiko Mizuta5, Makoto Yoshino6.   

Abstract

In ten families with late-onset ornithine transcarbamylase (OTC) deficiency in male patients, three mutant alleles-R40H, R277W, and Y55D-were identified. In a total of 20 informative parent-offspring pairs, father-to-daughter transmission and mother-to-offspring transmission occurred in five (25%) and 15 (75%), respectively, indicating that paternal transmission contributes substantially to the pool of these mutant alleles. Relative reproductive fitness of males and females carrying the mutant alleles was calculated to be 0.49 and 0.89, respectively. Comparison of the life span of the mutant alleles, estimated on the basis of these fitness values with those associated with classic phenotype (neonatal onset) in which reproductive fitness of male patients was nil, revealed that mutant alleles associated with the late-onset phenotype were eliminated more slowly. This would allow the late-onset phenotype mutant alleles to be retained more frequently in a population than those associated with classic phenotype. Although heterozygous females carrying the late-onset phenotype mutant alleles were generally asymptomatic, one female carrying the R40H allele died after a hyperammonemic episode at the age of 18 years. Such heterozygous females should be alerted to possible hyperammonemic crisis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18030415     DOI: 10.1007/s10038-007-0212-8

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  18 in total

1.  Late-onset ornithine transcarbamylase deficiency in male patients: prognostic factors and characteristics of plasma amino acid profile.

Authors:  Eimei Harada; Atsushi Nishiyori; Yasuyuki Tokunaga; Yoriko Watanabe; Norikazu Kuriya; Ryukichi Kumashiro; Tateo Kuno; Ryuichi Kuromaru; Shinichi Hirose; Kotaro Ichikawa; Makoto Yoshino
Journal:  Pediatr Int       Date:  2006-04       Impact factor: 1.524

2.  A novel missense mutation in exon 8 of the ornithine transcarbamylase gene in two unrelated male patients with mild ornithine transcarbamylase deficiency.

Authors:  A Hata; T Matsuura; C Setoyama; K Shimada; T Yokoi; I Akaboshi; I Matsuda
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

3.  The R40H mutation in a late onset type of human ornithine transcarbamylase deficiency in male patients.

Authors:  A Nishiyori; M Yoshino; H Kato; T Matsuura; R Hoshide; I Matsuda; T Kuno; S Miyazaki; S Hirose; R Kuromaru; M Mori
Journal:  Hum Genet       Date:  1997-02       Impact factor: 4.132

4.  Y55D mutation in ornithine transcarbamylase associated with late-onset hyperammonemia in a male.

Authors:  A Nishiyori; M Yoshino; Y Tananari; T Matsuura; R Hoshide; I Mastuda; M Mori; H Kato
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

5.  Sudden onset of ornithine carbamoyltransferase deficiency after aspirin ingestion.

Authors:  I Yoshida; M Yoshino; J Watanabe; F Yamashita
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Relative frequency of mutations causing ornithine transcarbamylase deficiency in 78 families.

Authors:  M Tuchman; R J Plante; M A Garcia-Perez; V Rubio
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

7.  Ornithine transcarbamylase deficiency in male adolescence and adulthood.

Authors:  M Yoshino; J Nishiyori; F Yamashita; R Kumashiro; H Abe; K Tanikawa; T Ohno; K Nakao; N Kaku; H Fukushima
Journal:  Enzyme       Date:  1990

8.  Phenotypic variability in male patients carrying the mutant ornithine transcarbamylase (OTC) allele, Arg40His, ranging from a child with an unfavourable prognosis to an asymptomatic older adult.

Authors:  I Matsuda; T Matsuura; A Nishiyori; S Komaki; R Hoshide; T Matsumoto; M Funakoshi; K Kiwaki; F Endo; A Hata; M Shimadzu; M Yoshino
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

Review 9.  The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency.

Authors:  I Matsuda; S Tanase
Journal:  Am J Med Genet       Date:  1997-09-05

10.  Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential.

Authors:  J A Arranz; E Riudor; C Marco-Marín; V Rubio
Journal:  J Inherit Metab Dis       Date:  2007-03-01       Impact factor: 4.750

View more
  2 in total

Review 1.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

2.  Contiguous Xp11.4 Gene Deletion Leading to Ornithine Transcarbamylase Deficiency Detected by High-density Single-nucleotide Array.

Authors:  Mizuho Ono; Junnosuke Tsuda; Yoko Mouri; Junichi Arai; Tadao Arinami; Emiko Noguchi
Journal:  Clin Pediatr Endocrinol       Date:  2010-05-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.